Inside story on SA's second Covid-19 vaccine trial: Wits vaccinology Professor Shabir Madhi

Loading player...
University of the Witwatersrand vaccinology expert Professor Shabir Madhi tells BizNews about how US drug company Novavax got to run a critical trial of its coronavirus vaccine. He shares the details of why this is a promising vaccine and picks up on the latest developments on Covid-19 vaccine trials in South Africa. Learn more about your ad choices. Visit megaphone.fm/adchoices
17 Aug 2020 4PM English South Africa Investing · Business News

Other recent episodes

Solly Moeng on Ramaphosa, his shadowy advisers and a fading legacy

In their weekly chat Chris Steyn and political commentator Solly Moeng dissect President Cyril Ramaphosa’s tough week on several fronts: The Madlanga Commission of Inquiry is seeking answers from his very influential former adviser, Dr Bejani Chauke, particularly in relation to WhatsApp chats with a notorious late taxi boss; his…
29 Oct 10AM 21 min